Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.37
-0.40 (-4.09%)
Mar 27, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Biotechnology
48.27M155.84M54.00M172.83M34.76M
Biotechnology Growth
-69.03%188.60%-68.76%397.17%11.23%
Total
48.27M155.84M54.00M172.83M34.76M
Total Growth
-69.03%188.60%-68.76%397.17%11.23%

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Germany
48.27M155.84M54.00M172.83M34.76M
Germany Growth
-69.03%188.60%-68.76%397.17%11.23%
Total
48.27M155.84M54.00M172.83M34.76M
Total Growth
-69.03%188.60%-68.76%397.17%11.23%
Source: S&P Global Market Intelligence.